US 8309527
Immunomodulatory oligonucleotides
granted A61KA61K2039/55561A61K31/4706
Quick answer
US patent 8309527 (Immunomodulatory oligonucleotides) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/55561, A61K31/4706, A61K39/39